FBI Probes Jim Irsay Death Over Prescription Drugs, Ketamine Use and Doctor Relationship: Report

The unexpected death of Jim Irsay, the longtime owner of the Indianapolis Colts, has prompted a federal investigation into the circumstances surrounding his passing. According to recent reports, the FBI is examining Irsay’s use of prescription medications, ketamine treatments, and his connection with a California-based addiction specialist. This probe aims to uncover critical details about the role these factors may have played in his death and to scrutinize the medical and legal aspects involved.

FBI Investigation into Jim Irsay’s Prescription Drugs and Ketamine Use

Federal authorities have launched an inquiry into Jim Irsay’s death, focusing on his alleged use of prescription drugs and ketamine, a powerful anesthetic sometimes used off-label for addiction treatment. The FBI reportedly issued a federal grand jury subpoena seeking records related to Irsay’s medical history, drug use, and his relationship with Dr. Harry Haroutunian, an addiction specialist from California who treated Irsay in the months leading up to his death.

Investigators spent several days in Indianapolis collecting evidence and interviewing relevant parties as part of the ongoing probe. While the FBI has declined to comment publicly, the Colts organization has acknowledged awareness of the investigation but stated they have not been contacted or served with subpoenas.

Background on Jim Irsay’s Health and Addiction Struggles

Jim Irsay, who took ownership of the Colts in 1997, had a well-documented history of health challenges and battles with substance abuse. Over the years, he openly admitted to multiple stints in rehabilitation, reportedly attending rehab at least 15 times to address addiction issues. His struggles with drugs and alcohol were public knowledge, and he faced legal consequences, including a 2014 arrest for operating while intoxicated (OWI), which resulted in an NFL suspension and a hefty fine.

In early 2024, the Colts announced that Irsay was being treated for a severe respiratory illness. Despite this, he appeared optimistic in social media posts, indicating he was “on the mend.” However, his health remained fragile, and in December 2023, police responded to a call at his home where he was found unresponsive, an incident authorities initially described as a suspected overdose. Irsay later disputed the overdose claim, emphasizing that the media had jumped to conclusions based on his past.

Role of Dr. Harry Haroutunian and Prescription Practices

Central to the FBI’s investigation is Dr. Harry Haroutunian, the addiction specialist who treated Irsay in the months before his death. Reports indicate that Haroutunian prescribed over 200 opioid pills to Irsay during this period. Additionally, ketamine treatments were administered amid Irsay’s relapse struggles. The use of ketamine in addiction therapy is controversial and not universally accepted, which adds complexity to the investigation.

Notably, Irsay’s death certificate was signed by Dr. Haroutunian, listing cardiac arrest caused by acute pneumonia as the official cause of death, with heart conditions cited as contributing factors. However, no formal autopsy was conducted, raising questions about the thoroughness of the medical examination and whether drug use was adequately considered in determining the cause of death.

Impact on the Indianapolis Colts and NFL Community

Jim Irsay’s death marks a significant moment for the Indianapolis Colts and the broader NFL community. As the youngest NFL owner when he assumed control of the team at age 37, Irsay was a prominent figure in professional football. Under his leadership, the Colts won 258 games, secured 10 division titles, made 18 playoff appearances, and reached two Super Bowls.

The Colts organization has maintained a cautious stance regarding the FBI investigation, emphasizing their cooperation with authorities while denying any direct involvement or knowledge of subpoenas. The probe’s outcome could have implications for how addiction treatment and prescription drug use are managed among high-profile sports executives and public figures.

Conclusion

The FBI’s investigation into Jim Irsay’s death highlights critical issues surrounding prescription drug use, ketamine treatments, and medical oversight in addiction care. As the probe unfolds, it may reveal important insights into the challenges faced by individuals battling addiction and the responsibilities of healthcare providers. For those interested in the latest developments on this story and its impact on the sports world, staying informed is essential.

If you want to keep up with breaking news and in-depth coverage on Jim Irsay and related topics, subscribe to our newsletter and follow our updates regularly.